GROWTH HORMONE DEFICIENCY WITHOUT EPIPHYSEAL CLOSURE

Clinical trials for GROWTH HORMONE DEFICIENCY WITHOUT EPIPHYSEAL CLOSURE explained in plain language.

Never miss a new study

Get alerted when new GROWTH HORMONE DEFICIENCY WITHOUT EPIPHYSEAL CLOSURE trials appear

Sign up with your email to follow new studies for GROWTH HORMONE DEFICIENCY WITHOUT EPIPHYSEAL CLOSURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Tracking kids on growth hormone therapy for years to come

Disease control Ongoing

This study is monitoring the long-term safety and growth effects of Ngenla, an approved treatment for children with growth hormone deficiency. It will follow children (boys under 15, girls under 13) who are starting Ngenla treatment for the first time. Researchers will track thei…

Matched conditions: GROWTH HORMONE DEFICIENCY WITHOUT EPIPHYSEAL CLOSURE

Sponsor: Pfizer • Aim: Disease control

Last updated Mar 23, 2026 15:14 UTC

GROWTH HORMONE DEFICIENCY WITHOUT EPIPHYSEAL CLOSURE

Get alerted when new GROWTH HORMONE DEFICIENCY WITHOUT EPIPHYSEAL CLOSURE trials appear

Tracking kids on growth hormone therapy for years to come